Columbia Sportswear Co. (COLM) Jumps 17.15% on February 12

Equities Staff  |

Columbia Sportswear Co. (COLM) was among the biggest gainers on the Russell 2000 for Friday February 12 as the stock popped 17.15% to $56.16, representing a gain of $8.22 per share. Some 2.04 million shares traded hands on 17,656 trades, compared with an average daily volume of 461,917 shares out of a total float of 70.32 million. The stock opened at $55.94 and traded with an intraday range of $57.20 to $53.25.

After today's gains, Columbia Sportswear Co. reached a market cap of $3.95 billion. Columbia Sportswear Co. has had a trading range between $74.72 and $42.01 over the last year, and it had a 50-day SMA of $47.92 and a 200-day SMA of $55.93.

The stock has a P/E Ratio of 20.4.

Columbia Sportswear Co designs, develops, markets and distributes active outdoor apparel, footwear, accessories and equipment under four brands namely Columbia, Mountain Hardwear, prAna and Montrail.

Columbia Sportswear Co. is based out of Portland, OR and has some 5,326 employees. Its CEO is Timothy P. Boyle.

For a complete fundamental analysis analysis of Columbia Sportswear Co., check out’s Stock Valuation Analysis report for COLM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.